Richard J. Honeywell

Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance

Kristy J. Gotink, Henk J. Broxterman, Mariëtte Labots et al. · Clinical Cancer Research · 2011 · 340 citations · Full text

Medicine, Oncology, Pharmacology +14

Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia

Mina Maftouh, Abolfazl Avan, Rocco Sciarrillo et al. · British Journal of Cancer · 2013 · 178 citations · Full text

Medicine, Oncology, Pharmacology +17

Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells

Amir Avan, Francesco Crea, Elisa Paolicchi et al. · Molecular Cancer Therapeutics · 2012 · 98 citations · Full text

Medicine, Oncology, Pharmacology +17

Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry

Richard J. Honeywell, K. Yarzadah, Elisa Giovannetti et al. · Journal of Chromatography B · 2010 · 95 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +15

Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer

J. Sigmond, Richard J. Honeywell, Tjeerd J. Postma et al. · Annals of Oncology · 2008 · 90 citations · Full text

Medicine, Oncology, Pharmacology +14